股票代码 | 603079 | 当期评分 | ||||
股票名称 | 圣达生物 | |||||
报告日期 | 2018-12-31 | 2019-12-31 | 2020-09-30 | 2020-09-30 | 2020-09-30 | 2020-09-30 |
每股经营现金流(¥) | 0.7918 | 0.5228 | 1.4535 | 1.4535 | 1.4535 | ✘ |
销售净利润率(%) | 8.6428 | 7.2733 | 29.5478 | 29.5478 | 29.5478 | ✔ |
销售毛利率(%) | 31.9782 | 35.9306 | 56.1597 | 56.1597 | 56.1597 | ✔ |
净资产收益率(%) | 5.63 | 5.32 | 15.33 | 15.33 | 15.33 | ✘ |
营业增长率(%) | -3.1169 | 5.3662 | 78.3452 | 78.3452 | 78.3452 | ✔ |
净利润增长率(%) | -41.3529 | -11.3296 | 378.6082 | 378.6082 | 378.6082 | ✔ |
每股收益(%) | 0.4 | 0.42 | 0.9 | 0.53 | 1.19 | ✔ |
现金流量比率(%) | 21.2756 | 15.7603 | 29.6061 | -0.8815 | 74.1421 | ✔ |
三项费用比重(%) | 16.156 | 19.2854 | 15.1311 | 13.0419 | 17.9932 | ✔ |
每股净资产(¥) | 7.0647 | 7.8912 | 7.3523 | 9.6853 | 7.6384 | ✔ |
流动比率(%) | 1.3669 | 1.9392 | 2.4042 | 2.0839 | 2.553 | ✔ |
速动比率(%) | 1.0675 | 1.4692 | 1.8885 | 1.6289 | 2.0735 | ✔ |
现金比率(%) | 72.2739 | 88.1419 | 110.2878 | 97.3603 | 97.3603 | ✔ |
总资产利润率(%) | 3.8043 | 2.7113 | 9.4791 | 3.8729 | 12.298 | ✔ |
主营利润比重% | 300.6937 | 379.3227 | 149.4715 | 142.9677 | 162.1818 | ✔ |
应收账款(万元) | 10,286.68 | 10,430.14 | 19,642.14 | 17,462.01 | 13,376.79 | ✔ |
应收票据(万元) | 363.11 | 168.58 | 157.25 | 120.60 | 71.90 | ✔ |
预付款项(万元) | 362.77 | 249.90 | 641.67 | 370.49 | 717.19 | ✔ |
存货(万元) | 12,481.53 | 17,462.07 | 17,390.09 | 17,072.66 | 16,092.00 | ✔ |
在建工程(万元) | 16,379.25 | 9,318.88 | 9,940.84 | 9,295.50 | 9,848.95 | ✔ |
应付款项(万元) | 10,020.38 | 8,619.51 | 6,590.64 | 6,122.60 | 5,625.58 | ✔ |
长期借款(万元) | 500.00 | 500.83 | 500.60 | 500.75 | -- | ✔ |
未分配利润(万元) | 21,698.04 | 24,737.41 | 38,412.95 | 30,980.17 | 43,310.69 | ✔ |
商誉(万元) | 1,090.94 | 1,090.94 | 1,090.94 | 1,090.94 | 1,090.94 | ✔ |
流动资产(万元) | 68,293.40 | 81,213.68 | 82,058.25 | 81,291.85 | 81,519.41 | ✔ |
流动负债(万元) | 41,684.39 | 37,152.66 | 33,725.41 | 37,526.63 | 33,559.37 | ✔ |
圣达生物603079评分结果 | 90.91分 | 买入/增持 |